Edesa Biotech
EDSA
Edesa Biotech (EDSA) earnings history
Most recent quarter
- Fiscal period
- Q4 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.37
- EPS estimate
- −$0.27
- EPS surprise
- −36.86%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Dec 12, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2025 | Dec 12, 2025 | −$0.27 | −$0.37 | −36.86% | $0.00 | SEC |
| Q3 2025 | Aug 8, 2025 | −$0.26 | −$0.25 | +5.05% | $0.00 | SEC |
| Q2 2025 | May 14, 2025 | −$0.42 | −$0.30 | +28.57% | $0.00 | SEC |
| Q1 2025 | Feb 14, 2025 | −$0.31 | −$0.48 | −54.84% | $0.00 | SEC |
| Q4 2024 | Dec 13, 2024 | −$0.54 | −$0.29 | +46.30% | $0.00 | SEC |
| Q3 2024 | Aug 9, 2024 | −$0.58 | −$0.52 | +10.34% | $0.00 | SEC |
| Q2 2024 | May 10, 2024 | −$0.69 | −$0.58 | +16.34% | $0.00 | SEC |
| Q1 2024 | Feb 9, 2024 | −$1.21 | −$0.54 | +55.37% | $0.00 | SEC |
| Q4 2023 | Dec 15, 2023 | −$0.70 | −$0.57 | +18.95% | $0.00 | SEC |
| Q3 2023 | Aug 9, 2023 | −$1.10 | −$0.70 | +36.17% | $0.00 | SEC |
| Q2 2023 | May 11, 2023 | −$1.14 | −$0.84 | +26.53% | $0.00 | SEC |
| Q1 2023 | Feb 10, 2023 | −$1.24 | −$0.91 | +26.42% | $0.00 | SEC |
| Q4 2022 | Dec 16, 2022 | −$2.19 | −$1.05 | +52.13% | $0.00 | — |
| Q3 2022 | Aug 12, 2022 | −$2.59 | −$2.59 | +0.00% | $0.00 | — |
| Q2 2022 | May 13, 2022 | −$2.57 | −$2.31 | +10.00% | $0.00 | — |
| Q1 2022 | Feb 14, 2022 | −$2.80 | −$2.31 | +17.50% | $0.00 | — |
| Q4 2021 | Dec 28, 2021 | −$2.57 | −$2.03 | +20.91% | $0.00 | — |
| Q3 2021 | Aug 13, 2021 | −$2.24 | −$2.52 | −12.50% | $0.00 | — |
| Q2 2021 | May 14, 2021 | −$2.07 | −$1.33 | +35.59% | $0.00 | — |
| Q1 2021 | Feb 16, 2021 | −$1.47 | −$1.82 | −23.81% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Edesa Biotech (EDSA) last report earnings?
Edesa Biotech last reported on Dec 12, 2025, covering fiscal Q4 2025.
Did EDSA beat earnings estimates?
No. Edesa Biotech reported EPS of −$0.37 for Q4 2025 against a −$0.27 estimate — a 36.86% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.